Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03353675
Title A Study Evaluating the Efficacy and the Safety of First-line Chemotherapy Combined With TG4010 and Nivolumab in Patients With Advanced Non-squamous Non-Small Cell Lung Cancer (NSCLC)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Transgene

lung non-small cell carcinoma


MVA-MUC1-IL2 vaccine + Nivolumab

Age Groups: senior | adult
Covered Countries USA | FRA | BEL

No variant requirements are available.